Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-106918
Filing Date
2024-12-09
Accepted
2024-12-09 16:00:25
Documents
1
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3984
  Complete submission text file 0001213900-24-106918.txt   5387
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 476 MASSACHUSETTS AVE, UNIT 2 BOSTON MA 02118
Business Address
Tesi Raymond Joseph (Reporting) CIK: 0001767280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38793 | Film No.: 241535017